製品の概要

  • 製品名N6-Cyclopentyladenosine (CPA)
  • 製品の詳細
    Potent, selective A1 agonist
  • 別名
    • CPA
  • 生理活性の詳細Potent and selective adenosine A1 receptor agonist (Ki values are 2.3, 790 and 43 nM for human A1, A2A and A3 receptors, respectively). Centrally active following systemic administration in vivo. Anticonvulsant, with cardiovacular actions, and effects on sleep regulation.
  • 精製度> 99%

製品の特性

    N6-Cyclopentyladenosine (CPA) (ab120398) 使用論文

    This product has been referenced in:
    • Klotz KN Adenosine receptors and their ligands. Naunyn Schmiedebergs Arch Pharmacol 362:382-91 (2000). Read more (PubMed: 11111832) »
    • Schwierin B  et al. Effects of N6-cyclopentyladenosine and caffeine on sleep regulation in the rat. Eur J Pharmacol 300:163-71 (1996). Read more (PubMed: 8739204) »
    • Williams M  et al. Evaluation of the binding of the A-1 selective adenosine radioligand, cyclopentyladenosine (CPA), to rat brain tissue. Naunyn Schmiedebergs Arch Pharmacol 332:179-83 (1986). Read more (PubMed: 3703020) »

    See all 4 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120398.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"